# FDA Inspection 873626 - Rivopharm S.A. - April 03, 2014

Source: https://www.keypedia.com/records/fda_inspections/rivopharm-sa/cf76f0c1-f974-4ea9-9e00-5cfee7d67661
Source feed: FDA_Inspections

> FDA Inspection 873626 for Rivopharm S.A. on April 03, 2014. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 873626
- Company Name: Rivopharm S.A.
- Inspection Date: 2014-04-03
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1264905 - 2023-06-23](https://www.keypedia.com/records/fda_inspections/rivopharm-sa/479ea237-331a-4522-874e-78980314694e)
- [FDA Inspection 1078356 - 2019-01-18](https://www.keypedia.com/records/fda_inspections/rivopharm-sa/6be8540d-455e-43b7-b5df-0663469a646c)
- [FDA Inspection 948852 - 2015-10-30](https://www.keypedia.com/records/fda_inspections/rivopharm-sa/1db04c02-d7c7-4b36-957e-643d5aad923d)

Company: https://www.keypedia.com/companies/rivopharm-sa/7cc8f5f7-352e-451c-bd6f-5abaec132ce0

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c